Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-025624
Filing Date
2022-07-07
Accepted
2022-07-07 07:54:15
Documents
1
Period of Report
2022-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1549
  Complete submission text file 0000899243-22-025624.txt   2901
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Barton Debora (Reporting) CIK: 0001936730 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40603 | Film No.: 221070652